Biotech

All Articles

ReNeuron leaving behind AIM swap after missing fundraising goal

.ReNeuron has joined the long checklist of biotechs to leave behind London's intention stock exchang...

MBX declare IPO to take challenger to Ascendis right into phase 3

.MBX Biosciences has actually included in the current outbreak of IPO filings. The biotech, which fi...

FDA grows probing into Lykos' MDMA tests: WSJ

.For Lykos Therapies and also the business's would-be MDMA-assisted therapy for trauma (POST-TRAUMAT...

Gene publisher Volume giving up 131 workers

.Just times after gene publisher Volume Biosciences declared undisclosed operational slices, a more ...

Repare gives up 25% of team as biotech standstills preclinical R&ampD

.Repare Therapeutics is giving up an one-fourth of its own workforce as the oncology biotech lessen ...

J &amp J files for FDA permission of $6.5 B autoimmune medication

.Johnson &amp Johnson has gotten an additional action toward understanding a profit on its $6.5 bill...

Gain's phase 1 gain leads way to verify Parkinson's drug's worth

.Increase Therapeutics has actually specified its own direct verifying the effectiveness of its Park...

Actinogen files brand new phase 2 records to salvage clinical depression medication

.Actinogen Medical's chances-- as well as sell rate-- have recoiled slightly from earlier this month...

Pfizer as well as Crown jewel add Quotient to multibillion-dollar formula

.Flagship Pioneering as well as Pfizer have added Ratio in to their 10-program collaboration, inking...

Bayer pens $547M deal to push limits of noncoding RNA

.Bayer managers were actually interested to tension to Intense this summer months that the German ph...